News Story
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
- Articles
- 1
- Independent
- 1
- Vendor
- 0
- Near-identical
- 0
Ordered by publication time. The first one is marked first; anything flagged near-identical shares almost the same wording, which usually means the same press release rather than separate reporting. That is a measurement — a SimHash distance of at most 10 on the headline and excerpt — not an accusation.
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
techcrunch.com